Prostate Cancer Diagnosis, Treatment and Outcomes in Patients with Previous or Synchronous Colorectal Cancer: A Systematic Review of Published Evidence.
colorectal cancer
metachronous cancer
prostate cancer
synchronous cancer
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
15 Jun 2022
15 Jun 2022
Historique:
received:
30
05
2022
revised:
11
06
2022
accepted:
13
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
The management of patients with prostate cancer (PCa) and previous or synchronous colorectal cancer (CRC) represents a challenging issue. A systematic review was performed in May 2022 to summarize available evidence about the diagnosis, management, and outcomes of these patients. Twenty-seven studies involving 252 patients were identified. Overall, 163 (64.7%) and 89 (35.3%) patients had synchronous and metachronous PCa and CRC, respectively. In patients with synchronous diseases, PCa treatment involved active surveillance in 1 patient, radical prostatectomy (RP) in 36 patients, radiotherapy (RT) in 60 patients, RP plus RT in 1 patient, proton beam therapy in 1 patient, and cryoablation in 1 patient. In patients with previous CRC treatment, prostate biopsy was mostly performed by transrectal approach (
Identifiants
pubmed: 35741285
pii: diagnostics12061475
doi: 10.3390/diagnostics12061475
pmc: PMC9221875
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Robot Surg. 2022 Feb;16(1):189-192
pubmed: 33743146
Diagnostics (Basel). 2021 Feb 20;11(2):
pubmed: 33672461
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
pubmed: 22237781
BMC Cancer. 2017 Dec 13;17(1):848
pubmed: 29237415
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
Medicine (Baltimore). 2020 May 29;99(22):e20336
pubmed: 32481410
Brachytherapy. 2009 Oct-Dec;8(4):339-44
pubmed: 19428310
Front Oncol. 2020 Mar 24;10:345
pubmed: 32266135
Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):800-2
pubmed: 22234115
Int J Part Ther. 2021 Apr 20;8(2):82-88
pubmed: 34722814
Int J Environ Res Public Health. 2020 Feb 24;17(4):
pubmed: 32102283
Cancer. 1990 May 1;65(9):2091-100
pubmed: 2372775
Acta Chir Belg. 2019 Feb;119(1):47-51
pubmed: 29198168
Anticancer Res. 2019 Aug;39(8):4449-4454
pubmed: 31366543
Asian J Endosc Surg. 2016 May;9(2):142-5
pubmed: 27117964
Wideochir Inne Tech Maloinwazyjne. 2017;12(1):68-74
pubmed: 28446934
Front Surg. 2021 Apr 21;8:648345
pubmed: 33968975
Oncol Lett. 2011 Sep 1;2(5):817-819
pubmed: 22866133
Br J Radiol. 2016;89(1057):20150292
pubmed: 26539631
Urology. 2001 May;57(5):943-5
pubmed: 11337299
J Urol. 2005 Jan;173(1):82-5; discussion 85-6
pubmed: 15592034
Ann Surg Oncol. 2020 Oct;27(11):4286-4293
pubmed: 32500342
Urology. 1999 Oct;54(4):679-81
pubmed: 10510927
Int J Environ Res Public Health. 2022 Apr 15;19(8):
pubmed: 35457692
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMC Med Inform Decis Mak. 2007 Jun 15;7:16
pubmed: 17573961
Nat Clin Pract Oncol. 2005 May;2(5):271-4; quiz 1 p following 274
pubmed: 16264963
Eur J Radiol. 2015 Apr;84(4):563-7
pubmed: 25638578
Clin Genitourin Cancer. 2021 Oct;19(5):e286-e298
pubmed: 33958297
Int J Colorectal Dis. 2012 Nov;27(11):1501-8
pubmed: 22451255
Urology. 2001 Apr;57(4):800
pubmed: 11306416
J Surg Case Rep. 2020 Sep 21;2020(9):rjaa338
pubmed: 32994919
Eur Urol. 1997;31(3):380-1
pubmed: 9129936
Pract Radiat Oncol. 2012 Jul-Sep;2(3):e7-e13
pubmed: 24674130
Am J Mens Health. 2021 Sep-Oct;15(5):15579883211044881
pubmed: 34493123
Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):458-461
pubmed: 30224901
JBI Evid Synth. 2020 Oct;18(10):2127-2133
pubmed: 33038125
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Springerplus. 2016 Oct 12;5(1):1768
pubmed: 27795910
Urol J. 2018 May 03;15(3):134-136
pubmed: 29277880